产品名称：美国小鼠重组干扰素 IFN gamma蛋白

Introduction:

Interferon-γ (-γ, also known as Type II interferon or immune interferon) is a cytokine produced primarily by T-lymphocytes and natural killer cells. IFNγ is an important activator of macrophages and inducer of Class II major histocompatibility complex (MHC) molecule expression. Aberrant IFNγ expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFNγ in the immune system stems in part from its ability to inhibit viral replication directly, and most importantly from its immunostimulatory and immunomodulatory effects.

PrimCells is proud to offer the best-in-class recombinant IFN gamma, which is derived from mammalian expression system rather than traditional bacterial based systems. These proteins maintain high activity and are suitable for a range of activity based assay including in vivo dosing.
美国PrimCells品牌介绍
PrimCells是位于美国加州圣迭戈的一家**致力于细胞产品研发和解决方案提供的业内技术领导企业。
公司汇集了的生物医药技术专家，独立开发了多项原代细胞和干细胞相关的专有技术。 公司以“细胞研究的*优选择”为宗旨，自主研发*过70种产品，填补了多个特种细胞市场的空白。例如其诱导性表达细胞库和高效3D皮肤培养系统，皆为该类产品目前市场上少数的规模化供应商。此外，公司以高质量的数据与快速稳定的项目完成时间，长期为多家知名制药公司提供解决方案，获得用户**赞誉。   
PrimCells产品线：

• 报告基因干细胞        2. 原代细胞（含报告基因原代细胞）               3. 诱导性稳定细胞株

4. 人源重组蛋白               5.   型培养试剂      
PrimCells 解决方案
1.诱导性稳定细胞株开发 2. 原代细胞开发 3. 体外毒理和效能测试 4. 3D-皮肤培养
PrimCells合作伙伴及客户:
A．生物制药公司：辉瑞(Pfizer), 诺华(Novartis), 礼来(Eli2  Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和医药研发部门
B．科研机构：冷泉港实验室，哈佛医学院, 麻省理工（MIT）,， UCSF, NYU, Salk, UIUC, USC等